Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Diagnos Laboratorium Utama Tbk. (DGNS) vs Nippon Indosari Corpindo Tbk. (ROTI)

Diagnos Laboratorium Utama Tbk.Trading
Nippon Indosari Corpindo Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Diagnos Laboratorium Utama Tbk. dan Nippon Indosari Corpindo Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp232 (kapitalisasi pasar 316,25 M, volume 24 jam 41,7 rb), sedangkan Nippon Indosari Corpindo Tbk. diperdagangkan di Rp585 (kapitalisasi pasar 3,65 T, volume 24 jam 185,6 rb). Perbedaan utamanya: Nippon Indosari Corpindo Tbk. jauh lebih besar — sekitar 11,5× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Nippon Indosari Corpindo Tbk. lebih aktif diperdagangkan (185,6 rb vs 41,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

DGNSROTI
Kapitalisasi Pasar
316,25 M3,65 T
Volume
41,7 rb185,6 rb
Lot
4171,86 rb
Perputaran
9,66 jt109,21 jt
Harga Rata-rata
231,65588,44
Nilai Transaksi
9,66 jt109,21 jt
Harga Ekuilibrium Indikatif
230585
Volume Ekuilibrium Indikatif
2,4 rb300

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

DGNS
Lihat detail
ROTI
Lihat detail

Tentang Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Selengkapnya di halaman DGNS

Tentang Nippon Indosari Corpindo Tbk.

PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.

Selengkapnya di halaman ROTI